Stock report · Delisted · Nasdaq
Hillevax Inc (HLVX)
2.09USD Delisted Final close · Sep 16, 2025
HLVX no longer trades. Hillevax was delisted from the Nasdaq in September 2025.
All prices on this page are historical. The last trade was on September 16, 2025, at $2.09.
HLVX stock price history
Final trading statistics
- Final close
- $2.09
- Final trading day
- Sep 16, 2025
- Market cap at delisting
- $104.76M
- Shares outstanding
- 50.13M
- Final 52-week range
- $1.34 – $2.17
- Avg. volume (final 3 mo.)
- 718,730
- All-time high
- $22.01 · Sep 2022
- All-time low
- $1.39 · Apr 2025
- Return since IPO
- -89.1%
- Beta
- 0.77
- Book value / share
- $2.99
- Price / book
- 0.70
About Hillevax Inc
HilleVax, Inc. was a clinical-stage biopharmaceutical company developing vaccines in the United States. Its candidate HIL-214 was a virus-like particle vaccine meant to prevent moderate-to-severe acute gastroenteritis from norovirus, licensed from Takeda Vaccines, Inc. Known as MokshaCo, Inc. until February 2021, the company was founded in 2019 and based in Boston. It became a subsidiary of XOMA Royalty Corporation as of September 17, 2025, and its stock was delisted from the Nasdaq that month, with the last trade on September 16, 2025 at $2.09.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Boston, MA
- Employees
- 14
- IPO date
- April 29, 2022
- Delisted
- September 16, 2025
- SEC CIK
- 1888012
Hillevax financials before the delisting
The last 5 fiscal years Hillevax reported as a public company, fiscal year ending December.
HLVX revenue and net income
HLVX earnings per share
HLVX annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$147.3M | −$3.00 |
| FY2023 | $0.00 | −$123.6M | −$3.04 |
| FY2022 | $0.00 | −$257.0M | −$13.10 |
| FY2021 | $0.00 | −$85.0M | −$9.01 |
| FY2020 | $0.00 | −$2.1M | — |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Hillevax stock FAQ
What happened to Hillevax stock?
Hillevax was delisted from the Nasdaq in September 2025. The final close was $2.09 on September 16, 2025.
Can I still buy HLVX stock?
No. HLVX is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on September 16, 2025.
What was the last price of HLVX?
HLVX last closed at $2.09 on September 16, 2025, which valued the company at about $104.76M.
How did Hillevax do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Hillevax reported revenue of $0.00 and net income of −$147.3M.
When did Hillevax go public?
Hillevax shares started trading on April 29, 2022.
HLVX no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.